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CSF Oligoclonal Bands in Multiple Sclerosis
I. Siddiqui,S. Aleem,N. Kayani  ( Departments of Pathology, The Aga Khan University, Karachi. ) 
S. Baig  ( Departments of Pathology, Medicine The Aga Khan University, Karachi. ) 
Abstract 
Objective: To study the significance of oligoclonal bands in neurological disorders, specifically in
Multiple Sclerosis (MS).
Methods: The study was designed to assess the sensitivity and specificity of the test methodology of
CSF electrophoresis by performing the retrospective analysis of CSF samples sent for oligoclonal
bands (OCB). A total of 603 samples were received by the Clinical Laboratories, Department of
Pathology of The Aga Khan University, during a period of 54 months (January 1993-June 1997). All of
these samples were analyzed by performing CSF protein electrophoresis. One hundred thirtythree out
of 603 samples showed evidence of OCB. Out of these, 24 patients were registered with Section of
Neurology, Department of Medicine, The Aga Khan University Hospital. These 24 patients were finally
selected for analysis. Relevant clinical details such as age, sex and clinical presentations were recorded.
Results: Fifteen (62%) out of 24 patients with positive OCB were diagnosed as cases of MS. Four
(17%) patients were diagnosed to have subacute sclerosing panencephalitis (SSPE). Five (21%)
patients were having other inflammatory neurological disorders.
Conclusion: The overall relative sensitivity and specificity for multiple sclerosis were found to be
100% and to the fact that OCB were positive in other neurological 62.5% respectively. Lack of
specificity was attributed disorders as well (JPMA 52:351; 2002).
Introduction 
Multiple Sclerosis (MS) is an inflammatory disorder of the central nervous system (CNS). MS is
common in Western countries especially in the northern part of Europe. However, less commonly it is
also seen in Asian countries1,2. It has a prevalence rate of 30 per 100,000 in high frequency areas such
as United Kingdom3. Multiple Sclerosis is an autoimmune organ specific disease of CNS characterized
by inflammation and demyelination4. The typical symptoms include, visual disturbances, optic neuritis,
diplopia, nystagmus, dysarthria, weakness, parasthesia, bladder abnormalities and mood alterations5.
Intelligence and implicit memory appear to be relatively preserved.
Susceptibility of MS is found to be associated with HLA-DR2 Haplotype. Antibodies specific for
defined HLA-DR2 peptide complex are important tools for studying antigen presentation in MS6.
Primary target antigen seems to be Myelin Basic Protein (MBP) due to its prominence in CNS myelin.
Immunogenic properties and encephalitogenicity for inducing experimental allergic encephalitis has
been shown in an animal model of MS4,7. Antibodies to myelin components and various viruses are
present in CSF from patients with MS8,9. Oligoclonal IgG bands (OCB) in CSF are characteristic of
clinically defmite MS in most populations7,10,11. The presence of cerebrospinal fluid (CSF) oligoclonal
bands is one of the reliable laboratory tests for the diagnosis of inflammatory disorders of the nervous
system. CSF oligoclonal bands are present in 95-100% of patients with MS8,12. Isoelectric focusing
(IEF) is regarded as the gold standard for the detection of CNS inflammation13, In usual case control
studies done previously, OCB is detectable in about 95% of patients with clinically definite MS and 10-
15% of controls9,14. OCB are routinely found in encephalitis and meningitis caused by various agents
e.g. enterovirus, HSV1, HIV, measles and even bacterial infections15,16. The objective of our study was
to observe the sensitivity and specificity of OCB in multiple sclerosis and to find out the percentage
positivity of OCB in other neurological diseases. The method used for the study of CSF was
electrophoresis.
Materials and Methods 
A total of 603 CSFsamples were received by the Clinical Laboratories, Department of Pathology, Aga
Khan University, during a period of 54 months (January 1993-June 1997). All of these were subjected
to protein electrophoresis. One hundred and thirty-three of 603 samples showed evidence of OCB. Of
the 133 patients, twenty-four were registered with the Section of Neurology, Department of Medicine,
The Aga Khan University Hospital, Karachi who were finally selected for analysis. The criterion for
selection was that the registered patients with Section of Neurology, Department of Medicine, The Aga
Khan University Hospital and the inpatient records would be available for review. We did not perform
an age, sex and duration matched study because the number of pairs which matched for age, sex and
duration from the very start were insufficient. The CSF samples from these patients were obtained by
lumbar puncture. Relevant clinical details such as age, sex and clinical presentations were also
recorded. Other parameters taken into account during collection of data, included signs and symptoms
of the disease process and other investigative techniques performed.
Sample analysis
These samples collected were coded and sent to the laboratory for blind analysis. Classical protein
electrophoresis was done as described by Teitez17. The formula used was lgG/albumin index18 given
below: IgG (CSF) x Albumin (serum)fLgG (serum) x Albumin (CSF)
The principle of electrophoresis is electrophoretic separation on agrose medium with a subsequent
blotting with nitrocellulose membrane and visualization of separated protein bands with gold stain.
As a routine 5 micro liters unconcentrated CSF was used. If concentration of CSF protein was found
more than 70mg/dl, then CSF was diluted as required. Reagents used were Agrose gel (usually serum
protein gel is used), Nitrocellulose membrane, Filter papers, Gold Chloride (Chloro-auie acid),
Stannous Chloride, HCI Tween20 and Anhydrous Citric acid. Instruments in use were Beckman
electrophoretic chambers, Electric shakers and heavy weights to press the gel.
Procedure
One positive and one negative control with each strip containing 8 patient samples were prepared.
Electrophoresis procedure was performed for 30 minutes at constant voltage using the setting of
100mV.
For blotting, nitrocellulose membrane was used. After electrophoresis completion, the gel was removed
from the chamber and placed in a clean dry surface. The gel was over layered by sheet of Nitrocellulose
membrane and then pressed with few absorbent papers by keeping heavy weights on them for 30
minutes.
Incubation Gold Stain was prepared by adding to 75ml of deionized water the following reagents drop
wise with vigorous mixing: 1 ml of 1% aqueous gold chloride, 0.4 ml of 1% stannous (prepared by
dissolving 0.1gm stannous chloride in 0.5ml of 1M HCI and mixing to 10ml water to give a cloudy
solution), 10 ml of 2% aqueous Tween2O and finally 25 ml of 9.6g/l of anhydrous citric acid.
After removing the filter papers, the lower sheet was immersed in the Gold Stain at room temperature.
Staining was completed within 1 hour; after which the membrane was washed thoroughly with water
and interpreted and then stored after labelling. The results were visually interpreted by finding a
characteristic OCB in the gamma globulin region.
Results 
Twenty-four patients from the 133 positive samples were identified and included in the study for final
analysis. There were 19 males and 6 females with a mean age of 28 years (range 10-70 years). Fifteen
(62%)of 24 OCB positive patients were diagnosed as multiple sclerosis, while four (17%) as subacute
scierosing panencephalitis. The remaining five (2 1%) were found to have other neurological
inflammatory diseases. Comparison of OCB results was made with other investigative techniques like
MRI, AEP, VEP, which could be supportive to the diagnosis of MS. Most of these were concordant
with the final clinical diagnosis (Table 1).
The frequency of presenting symptoms like weakness in arms and legs, fever, vertigo and urine
incontinence etc. in cases of multiple sclerosis are shown in Table 2. ).
Discussion 
Many studies have been performed in Western countries, to determine the role of oligoclonal bands in
the diagnosis of multiple sclerosis and to find out the possible target for the antibodies18.
Studies carried out in the recent past used IEF of OCB as the diagnostic procedure. In most of the
studies carried out earlier19-22, OCB was detectable in about 95% of the patients compared with 10-
15% of controls. In a study carried out by T. Faukazawa et al.1, OCB in CSF was found to have a lesser
diagnostic value in Japan as compared to Western countries.
Our study on OCB in MS is one of very few studies carried out in Pakistan. Cases clinically diagnosed,
as multiple sclerosis without oligoclonal bands in CSF are not confirmatory.
The CSF OCB usually differs between patients with MS, but they remain remarkably constant for most
patients even over 10 years23,24 and even after immunotherapy25. This phenomenon in addition to
temporal separation of multifocal lesions is useful in distinguishing chronic inflammatory conditions,
such as MS and SSPE, from acute post-infectious demyelinating diseases13.
As described in a previous study18, the presence of oligoclonal bands was the most sensitive test for
MS with a 100% sensitivity rate and a specificity of 82%. The visual evoked response was the next
most sensitive study12. The results correlate closely with our local findings.
OCB in definite MS is mainly limited to establishing a diagnosis, but because of their non-specificity,
the results must be interpreted in the context of the clinical diagnosis. As the sensitivity is high, all
patients with susceptible MS and a normal CSF immunoglobulin, should have other diagnosis
rigorously excluded3.
We concluded from our study that oligoclonal bands have high sensitivity for multiple sclerosis;
however, specificity of OCB is just 62.50%. This lack of specificity can be attributed to the fact that
oligoclonal bands were positive in other neurological disorders.
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